Use of fluorescently-labeled nanoparticles to study pore morphology and virus capture in virus filtration membranes

[1]  A. Zydney,et al.  Probing effects of pressure release on virus capture during virus filtration using confocal microscopy , 2015, Biotechnology and bioengineering.

[2]  A. Zydney,et al.  Effects of solution conditions on virus retention by the Viresolve® NFP filter , 2015, Biotechnology progress.

[3]  A. Zydney,et al.  Internal virus polarization model for virus retention by the Ultipor® VF Grade DV20 membrane , 2014, Biotechnology progress.

[4]  A. Zydney,et al.  Effects of a pressure release on virus retention with the Ultipor DV20 membrane , 2014, Biotechnology and bioengineering.

[5]  A. Zydney,et al.  Use of confocal scanning laser microscopy to study virus retention during virus filtration , 2011 .

[6]  J. Pellegrino,et al.  Characterization of asymmetry in microporous membranes by cross-sectional confocal laser scanning mi , 2011 .

[7]  Scott M. Husson,et al.  Understanding virus filtration membrane performance , 2010 .

[8]  Mark Hernandez,et al.  Fluorescent microspheres as virion surrogates in low-pressure membrane studies , 2009 .

[9]  S. Wickramasinghe.  Tangential‐Flow Filtration for Virus Capture , 2008 .

[10]  Gail Sofer,et al.  Viral Clearance: A Strategy for Quality by Design and the Design Space , 2008 .

[11]  A. Zydney,et al.  Effect of solution pH on protein transmission and membrane capacity during virus filtration , 2008, Biotechnology and bioengineering.

[12]  S. Lute,et al.  Phage passage after extended processing in small‐virus‐retentive filters , 2007, Biotechnology and applied biochemistry.

[13]  S. Spector,et al.  Increasing the capacity of parvovirus‐retentive membranes: performance of the Viresolve™ Prefilter , 2006, Biotechnology and applied biochemistry.

[14]  M. Krishnan,et al.  Virus removal by filtration : Points to consider , 2006 .

[15]  Herb Lutz,et al.  Viral filtration of plasma-derived human IgG , 2004 .

[16]  Kurt Brorson,et al.  Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow‐through mode , 2003, Biotechnology and bioengineering.

[17]  Kurt Brorson,et al.  Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. , 2003, Biotechnology and bioengineering.

[18]  F. Hesse,et al.  Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures. , 2000, Trends in biotechnology.

[19]  P. Roberts.  Virus safety in bio products , 1994 .

[20]  P. Mellor,et al.  Contamination of genetically engineered CHO-cells by epizootic haemorrhagic disease virus (EHDV). , 1993, Biologicals : journal of the International Association of Biological Standardization.

[21]  M. Wiebe,et al.  Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinations , 1985, Transfusion.